OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Impact of new generation hormone-therapy on cognitive function in elderly patients treated for a metastatic prostate cancer: Cog-Pro trial protocol
Marie Lange, Heidi Solem Laviec, Hélène Castel, et al.
BMC Cancer (2017) Vol. 17, Iss. 1
Open Access | Times Cited: 22
Marie Lange, Heidi Solem Laviec, Hélène Castel, et al.
BMC Cancer (2017) Vol. 17, Iss. 1
Open Access | Times Cited: 22
Showing 22 citing articles:
Recent Advances in Prostate Cancer Treatment and Drug Discovery
Ekaterina Nevedomskaya, Simon J. Baumgart, Bernard Haendler
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 5, pp. 1359-1359
Open Access | Times Cited: 232
Ekaterina Nevedomskaya, Simon J. Baumgart, Bernard Haendler
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 5, pp. 1359-1359
Open Access | Times Cited: 232
Hormonal treatment and quality of life of prostate cancer patients: new evidence
Marcello Tucci, Gianmarco Leone, Consuelo Buttigliero, et al.
Minerva Urology and Nephrology (2018) Vol. 70, Iss. 2
Closed Access | Times Cited: 51
Marcello Tucci, Gianmarco Leone, Consuelo Buttigliero, et al.
Minerva Urology and Nephrology (2018) Vol. 70, Iss. 2
Closed Access | Times Cited: 51
Chemotherapy and cognition: International cognition and cancer task force recommendations for harmonising preclinical research
Gordon Winocur, Ian Johnston, Hélène Castel
Cancer Treatment Reviews (2018) Vol. 69, pp. 72-83
Closed Access | Times Cited: 47
Gordon Winocur, Ian Johnston, Hélène Castel
Cancer Treatment Reviews (2018) Vol. 69, pp. 72-83
Closed Access | Times Cited: 47
Psychosocial Aspects of Living Long Term with Advanced Cancer and Ongoing Systemic Treatment: A Scoping Review
Evie E. M. Kolsteren, Esther Deuning‐Smit, Alanna K. Chu, et al.
Cancers (2022) Vol. 14, Iss. 16, pp. 3889-3889
Open Access | Times Cited: 27
Evie E. M. Kolsteren, Esther Deuning‐Smit, Alanna K. Chu, et al.
Cancers (2022) Vol. 14, Iss. 16, pp. 3889-3889
Open Access | Times Cited: 27
Correlation of Androgen Deprivation Therapy with Cognitive Dysfunction in Patients with Prostate Cancer: A Nationwide Population-Based Study Using the National Health Insurance Service Database
Bum Sik Tae, Byung Jo Jeon, Seung Hun Shin, et al.
Cancer Research and Treatment (2018) Vol. 51, Iss. 2, pp. 593-602
Open Access | Times Cited: 42
Bum Sik Tae, Byung Jo Jeon, Seung Hun Shin, et al.
Cancer Research and Treatment (2018) Vol. 51, Iss. 2, pp. 593-602
Open Access | Times Cited: 42
Impact of abiraterone acetate plus prednisone or enzalutamide on fatigue and cognition in patients with metastatic castration-resistant prostate cancer: initial results from the observational AQUARiUS study
Antoine Thiery-Vuillemin, Mads Hvid Poulsen, É. Lagneau, et al.
ESMO Open (2018) Vol. 3, Iss. 5, pp. e000397-e000397
Open Access | Times Cited: 40
Antoine Thiery-Vuillemin, Mads Hvid Poulsen, É. Lagneau, et al.
ESMO Open (2018) Vol. 3, Iss. 5, pp. e000397-e000397
Open Access | Times Cited: 40
Androgen receptor pathway inhibitors, prostate cancer, and older adults: a global Young International Society of Geriatric Oncology drug review
Nabiel Mir, Olivia Burke, Samuel J. Yates, et al.
Therapeutic Advances in Medical Oncology (2023) Vol. 15
Open Access | Times Cited: 10
Nabiel Mir, Olivia Burke, Samuel J. Yates, et al.
Therapeutic Advances in Medical Oncology (2023) Vol. 15
Open Access | Times Cited: 10
Toxicity profile characteristics of novel androgen-deprivation therapy agents in patients with prostate cancer: a meta-analysis
Jianhong Zhu, Rifang Liao, Chen Su, et al.
Expert Review of Anticancer Therapy (2017) Vol. 18, Iss. 2, pp. 193-198
Closed Access | Times Cited: 29
Jianhong Zhu, Rifang Liao, Chen Su, et al.
Expert Review of Anticancer Therapy (2017) Vol. 18, Iss. 2, pp. 193-198
Closed Access | Times Cited: 29
Cognition and depression effects of androgen receptor axis-targeted drugs in men with prostate cancer: A systematic review
Anupam Batra, Michele Marchioni, Ardeshir Z. Hashmi, et al.
Journal of Geriatric Oncology (2020) Vol. 12, Iss. 5, pp. 687-695
Closed Access | Times Cited: 18
Anupam Batra, Michele Marchioni, Ardeshir Z. Hashmi, et al.
Journal of Geriatric Oncology (2020) Vol. 12, Iss. 5, pp. 687-695
Closed Access | Times Cited: 18
Qualitative study of patients with metastatic prostate cancer to adherence of hormone therapy
Laura Iacorossi, Francesca Gambalunga, Rosaria De Domenico, et al.
European Journal of Oncology Nursing (2018) Vol. 38, pp. 8-12
Closed Access | Times Cited: 15
Laura Iacorossi, Francesca Gambalunga, Rosaria De Domenico, et al.
European Journal of Oncology Nursing (2018) Vol. 38, pp. 8-12
Closed Access | Times Cited: 15
How to assess and manage cognitive impairment induced by treatments of non-central nervous system cancer
Marie Lange, Hélène Castel, Johan Le Fel, et al.
Neuroscience & Biobehavioral Reviews (2019) Vol. 107, pp. 602-614
Open Access | Times Cited: 15
Marie Lange, Hélène Castel, Johan Le Fel, et al.
Neuroscience & Biobehavioral Reviews (2019) Vol. 107, pp. 602-614
Open Access | Times Cited: 15
Evaluation of Cognitive Function in Trials Testing New-Generation Hormonal Therapy in Patients with Prostate Cancer: A Systematic Review
Laura Marandino, Francesca Vignani, Consuelo Buttigliero, et al.
Cancers (2020) Vol. 12, Iss. 9, pp. 2568-2568
Open Access | Times Cited: 9
Laura Marandino, Francesca Vignani, Consuelo Buttigliero, et al.
Cancers (2020) Vol. 12, Iss. 9, pp. 2568-2568
Open Access | Times Cited: 9
Comparative efficacy of second-generation androgen receptor inhibitors for treating prostate cancer: A systematic review and network meta-analysis
Xiangyu Chen, Qihua Wang, Pan Yang, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 2
Xiangyu Chen, Qihua Wang, Pan Yang, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 2
Cancer de la personne âgée : rechercher, évaluer et prendre en charge le déclin cognitif
V. Antoine, Mireille Courtial, B. de Wazières, et al.
Bulletin du Cancer (2018) Vol. 105, Iss. 7-8, pp. 720-734
Closed Access | Times Cited: 5
V. Antoine, Mireille Courtial, B. de Wazières, et al.
Bulletin du Cancer (2018) Vol. 105, Iss. 7-8, pp. 720-734
Closed Access | Times Cited: 5
A drug safety evaluation of abiraterone acetate in the treatment of prostate cancer
Pietro Castellan, Roberto Castellucci, Michele Marchioni, et al.
Expert Opinion on Drug Safety (2019) Vol. 18, Iss. 9, pp. 759-767
Open Access | Times Cited: 5
Pietro Castellan, Roberto Castellucci, Michele Marchioni, et al.
Expert Opinion on Drug Safety (2019) Vol. 18, Iss. 9, pp. 759-767
Open Access | Times Cited: 5
Is There an Age Threshold for Holding Off on Testing Novel Therapies?
Olivia Le Saux, Claire Falandry
Current Oncology Reports (2018) Vol. 20, Iss. 1
Closed Access | Times Cited: 3
Olivia Le Saux, Claire Falandry
Current Oncology Reports (2018) Vol. 20, Iss. 1
Closed Access | Times Cited: 3
A review of the objective cognitive function measurements in males receiving hormonal therapy for prostate cancer
Thomas Neerhut, Brian Ng Hung Shin, Handoo Rhee, et al.
Investigative and Clinical Urology (2023) Vol. 64, Iss. 6, pp. 521-521
Open Access | Times Cited: 1
Thomas Neerhut, Brian Ng Hung Shin, Handoo Rhee, et al.
Investigative and Clinical Urology (2023) Vol. 64, Iss. 6, pp. 521-521
Open Access | Times Cited: 1
Correction to: Impact of new generation hormone-therapy on cognitive function in elderly patients treated for a metastatic prostate cancer: Cog-Pro trial protocol
Marie Lange, Heidi Solem Laviec, Hélène Castel, et al.
BMC Cancer (2018) Vol. 18, Iss. 1
Open Access | Times Cited: 2
Marie Lange, Heidi Solem Laviec, Hélène Castel, et al.
BMC Cancer (2018) Vol. 18, Iss. 1
Open Access | Times Cited: 2
Spécificités gériatriques du cancer de la prostate
P. Mongiat-Artus, Éléna Paillaud, Philippe Caillet, et al.
Progrès en Urologie (2019) Vol. 29, Iss. 14, pp. 828-839
Open Access | Times Cited: 1
P. Mongiat-Artus, Éléna Paillaud, Philippe Caillet, et al.
Progrès en Urologie (2019) Vol. 29, Iss. 14, pp. 828-839
Open Access | Times Cited: 1
The prostate cancer therapy enzalutamide compared with abiraterone acetate/prednisone impacts motivation for exploration, spatial learning and alters dopaminergic transmission in aged castrated mice
Celeste Nicola, Martine Dubois, Cynthia Campart, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 1
Celeste Nicola, Martine Dubois, Cynthia Campart, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 1
Comprehensive Review on Recent Strategies for Management of Prostate Cancer: Therapeutic Targets and SAR
Manish Chaudhary, Shubham Kumar, Paranjeet Kaur, et al.
Mini-Reviews in Medicinal Chemistry (2023) Vol. 24, Iss. 7, pp. 721-747
Closed Access
Manish Chaudhary, Shubham Kumar, Paranjeet Kaur, et al.
Mini-Reviews in Medicinal Chemistry (2023) Vol. 24, Iss. 7, pp. 721-747
Closed Access
